Ion transport and barrier function in a telomerase-immortalized human nondysplastic, Barrett's cell line (BAR-T)

Diseases of the Esophagus

Volumn 22, Issue 5, 2009, Pages 386-395

  Jovov, Biljana ^a   Orlando, Geraldine S ^a   Tobey, Nelia A ^a   Brown, Karen L ^b   Djukic, Zorka ^a   Carson, John L ^a   Brighton, Louisa E ^a   Orlando, Roy C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Claudin; HET 1A; Ion transport; Resistance; Tight junction; ZO1

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CLAUDIN; CLAUDIN 1; CLAUDIN 11; CLAUDIN 12; CLAUDIN 15; CLAUDIN 16; CLAUDIN 18; CLAUDIN 20; CLAUDIN 23; CLAUDIN 4; CLAUDIN 8; MESSENGER RNA; PROTEIN ZO1; UNCLASSIFIED DRUG;

ARTICLE; BARRETT ESOPHAGUS; BASOLATERAL MEMBRANE; CELL IMMORTALIZATION; CELL LINE; CELL MEMBRANE; CELL MEMBRANE RESISTANCE; CELL MEMBRANE STEADY POTENTIAL; CELL STRUCTURE; COLUMNAR EPITHELIUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOLOCALIZATION; ION TRANSPORT; MEMBRANE DEPOLARIZATION; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT CIRCUIT CURRENT; TIGHT JUNCTION;

4-ACETAMIDO-4'-ISOTHIOCYANATOSTILBENE-2,2'-DISULFONIC ACID; AUTOANTIGENS; BARRETT ESOPHAGUS; BUFFERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA; ELECTRIC CONDUCTIVITY; ELECTRIC IMPEDANCE; ENZYME INHIBITORS; EPITHELIAL CELLS; HEPES; HUMANS; ION TRANSPORT; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; OUABAIN; PHOSPHOPROTEINS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIGHT JUNCTIONS;

EID: 67949083717     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00907.x     Document Type: Article

References (40)

1. Orlando R C. Mucosal defense in Barrett's esophagus. In: Sharma P, Sampliner R, (eds). Barrett's Esophagus and Esophageal Adenocarcinoma, 2nd edn. Malden, MA: Blackwell Publishing, 2006; 60-72.
2. Johnson D A, Winters C, Spurling T J, Chobanian S J, Cattau E L Jr. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol 1987; 9: 23-7.
3. Rex D K, Cummings O W, Shaw M etal. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-7.
4. Gerson L B, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
5. Ouatu-Lascar R, Fitzgerald R C, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999; 117: 327-35.
6. Ouatu-Lascar R, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1998; 93: 711-6.
7. Ostrowski J, Mikula M, Karczmarski J et al. Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics. J Mol Med 2007; 85: 733-43.
8. Jovov B, Van Itallie C M, Shaheen N J et al. Claudin-18: A dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1106-13.
9. Orlando R C. Pathogenesis of reflux esophagitis and Barrett's esophagus. In: Cappell MS, (ed.). Medical Clinics of North America, Vol. 89. Philadelphia, PA: WB Saunders Company, 2005; 219-42.
10. Tobey N A, Argote C M, Vanegas X C, Barlow W, Orlando R C. Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium. Am J Physiol Gastrointest Liver Physiol 2007; 293: G264-70.
11. Abdulnour-Nakhoul S, Orlando R C. Lumen-to-surface pH gradient in Barrett's esophagus. Gastroenterology 2004; 126: A235.
12. Chen X, Qin R, Liu B et al. Multilayered epithelium in a rat model and human Barrett's esophagus: Similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol 2008; 8: 1.
13. Su Y, Chen X, Klein M et al. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: Similarity to human Barrett's esophagus. Lab Invest 2004; 84: 753-65.
14. Goldstein S R, Yang G Y, Curtis S K et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997; 18: 2265-70.
15. Palanca-Wessels M C, Barrett M T, Galipeau P C, Rohrer K L, Reid B J, Rabinovitch P S. Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology 1998; 114: 295-304.
16. Khan S M, Pillay S P, Papadimos D, Yong J W, Roberts H J, Crawford D H. A technique for the culture of Barrett's oesophageal cells. J Gastroenterol Hepatol 1997; 12: 606-11.
17. Vona-Davis L, Vincent T, Zulfiqar S, Jackson B, Riggs D, McFadden D W. Proteomic analysis of SEG-1 human Barrett's-associated esophageal adenocarcinoma cells treated with keyhole limpet hemocyanin. J Gastrointest Surg 2004; 8: 1018-23.
18. Piazuelo E, Jimenez P, Strunk M et al. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus. Prostaglandins Other Lipid Mediat 2006; 81: 150-61.
19. Sarosi G A Jr, Herndon K, Jaiswal E, Lopez-Guzman C, Spechler S J, Souza R F. Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/ HCO3-exchanger. Am J Physiol Gastrointest Liver Physiol 2005; 289: G991-7.
20. Souza R F, Shewmake K, Pearson S et al. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2004; 287: G743-8.
21. Jaiswal K R, Morales C P, Feagins L A et al. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis Esophagus 2007; 20: 256-64.
22. Jaiswal K, Lopez-Guzman C, Souza R F, Spechler S J, Sarosi G A Jr. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am J Physiol Gastrointest Liver Physiol 2006; 290: G335-42.
23. Ramirez R D, Morales C P, Herbert B S et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 2001; 15: 398-403.
24. Holmes J L, Van Itallie C M, Rasmussen J E, Anderson J M. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 2006; 6: 581-8.
25. Hamalainen H K, Tubman J C, Vikman S et al. Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem 2001; 299: 63-70.
26. Rahner C, Mitic L L, Anderson J M. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001; 120: 411-22.
27. Jovov B, Tousson A, McMahon L L, Benos D J. Immunolocalization of the acid-sensing ion channel 2a in the rat cerebellum. Histochem Cell Biol 2003; 119: 437-46.
28. Jovov B, Berdiev B K, Fuller C M, Ji H L, Benos D J. The serine protease trypsin cleaves C termini of beta- and gamma-subunits of epithelial Na+ channels. J Biol Chem 2002; 277: 4134-40.
29. Van Itallie C M, Gambling T M, Carson J L, Anderson J M. Palmitoylation of claudins is required for efficient tight-junction localization. J Cell Sci 2005; 118: 1427-36.
30. Tobey N A, Argote C M, Vanegas X C, Barlow W, Orlando R C. Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium. Am J Physiol Gastrointest Liver Physiol 2007; 293: G264-70.
31. Feagins L A, Zhang H Y, Hormi-Carver K et al. Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells. Am J Gastroenterol 2007; 102: 10-20.
32. Zhang H Y, Zhang X, Hormi-Carver K, Feagins L A, Spechler S J, Souza R F. In non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway. Cancer Res 2007; 67: 8580-7.
33. Hormi-Carver K, Feagins L A, Spechler S J, Souza R F. All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells. Am J Physiol Gastrointest Liver Physiol 2007; 292: G18-27.
34. Souza R F, Shewmake K, Terada L S, Spechler S J. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002; 122: 299-307.
35. Morgan C, Alazawi W, Sirieix P, Freeman T, Coleman N, Fitzgerald R. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line. Am J Gastroenterol 2004; 99: 218-24.
36. Aijaz S, Balda M S, Matter K. Tight junctions: Molecular architecture and function. Int Rev Cytol 2006; 248: 261-98.
37. Angelow S, Yu A S. Claudins and paracellular transport: An update. Curr Opin Nephrol Hypertens 2007; 16: 459-64.
38. Niessen C M. Tight junctions/adherens junctions: Basic structure and function. J Invest Dermatol 2007; 127: 2525-32.
39. Umeda K, Ikenouchi J, Katahira-Tayama S et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 2006; 126: 741-54.
40. Orlando R C, Lacy E R, Tobey N A, Cowart K. Barriers to paracellular permeability in rabbit esophageal epithelium. Gastroenterology 1992; 102: 910-23.